© 1995 American Heart Association, Inc.
Articles |
Effects of Antisense c-myb Oligonucleotides on Vascular Smooth Muscle Cell Proliferation and Response to Vessel Wall Injury
From the Center for Thrombosis and Vascular Biology, Department of Cardiology and the Department of Cell Biology, The Cleveland (Ohio) Clinic Foundation (A.E.V., L.A.G., E.J.P., S.D., E.F.P., P.E.D., E.J.T.); the Division of Pediatric Cardiology, University of Michigan Medical School, Ann Arbor (V.L., R.J.L.); and Amgen, Thousand Oaks, Calif (C.L.F.).
Correspondence to Eric J. Topol, MD, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail topole@ccsmtp.ccf.org.
Abstract The process of restenosis after arterial balloon dilatation has been demonstrated to involve smooth muscle cell hyperplasia. Initial reports with antisense oligonucleotides directed against the proto-oncogene c-myb suggest marked in vitro specificity and in vivo efficacy. In the present study, we sought to confirm and extend the hypothesis that antisense to c-myb results in a specific antiproliferative effect with a comprehensive assessment by using different oligonucleotide preparations, different species, and tissue and cellular uptake experiments. Phosphorothioate-protected oligonucleotides representing the appropriate sequence for antisense to c-myb and multiple controls were used to inhibit proliferation of platelet-derived growth factor– and fetal bovine serum–stimulated rat, dog, and human aortic smooth muscle cells in vitro and neointimal proliferation in the rat carotid injury model. In vitro experiments using identical culture conditions in rat, dog, and human aortic smooth muscle cells failed to show specificity as well as consistency in growth inhibitory effects that could be attributed to an antisense mechanism. Proliferation of smooth muscle cell growth in culture was consistently inhibited with oligomers containing a contiguous 4-guanosine residue motif. In vivo, the rat carotid injury neointimal hyperplasia was similar for antisense c-myb (0.095±0.009 mm2) and sense c-myb (0.090±0.009 mm2). Fluorescent-labeled oligonucleotides were present in tissue after local delivery via pluronic gel, and their activity rapidly declined over a 72-hour period. Our findings point to the potential nonspecificity and lack of consistency of the antisense oligonucleotide to c-myb in vitro and in vivo. An alternative nonantisense mechanism for the inhibition of smooth muscle cell proliferation, involving contiguous 4-guanosine residues, is proposed.
Key Words: antisense oligonucleotides • arterial injury • proto-oncogenes • smooth muscle cell proliferation • restenosis
This article has been cited by other articles:
 |
|
 |
|
  B. Polyak, I. Fishbein, M. Chorny, I. Alferiev, D. Williams, B. Yellen, G. Friedman, and R. J. Levy High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents PNAS, January 15, 2008; 105(2): 698 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lei, F. Liu, and S. A. Ness Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1 Blood, May 15, 2005; 105(10): 3855 - 3861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashi, H. Banno, K. Kadomatsu, Y. Takei, K. Komori, and T. Muramatsu Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2203 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-M. You, I. N. Mungrue, W. Kalair, T. Afroze, B. Ravi, A. M. Sadi, R. Gros, and M. Husain Conditional Expression of a Dominant-Negative c-Myb in Vascular Smooth Muscle Cells Inhibits Arterial Remodeling After Injury Circ. Res., February 21, 2003; 92(3): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Lambert, N. Malik, L. Shepherd, J. Gunn, S. E. Francis, A. King, D. C. Crossman, D. C. Cumberland, and C. M. Holt Localization of c-Myb and Induction of Apoptosis by Antisense Oligonucleotide c-myb After Angioplasty of Porcine Coronary Arteries Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1727 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Santiago, D. G. Atkins, and L. M. Khachigian Vascular Smooth Muscle Cell Proliferation and Regrowth after Mechanical Injury in Vitro Are Egr-1/NGFI-A-Dependent Am. J. Pathol., September 1, 1999; 155(3): 897 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gallo, A. Padurean, T. Jayaraman, S. Marx, M. Roque, S. Adelman, J. Chesebro, J. Fallon, V. Fuster, A. Marks, et al. Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell Cycle Circulation, April 27, 1999; 99(16): 2164 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Santiago, H. C. Lowe, F. L. Day, C. N. Chesterman, and L. M. Khachigian Early Growth Response Factor-1 Induction by Injury Is Triggered by Release and Paracrine Activation by Fibroblast Growth Factor-2 Am. J. Pathol., March 1, 1999; 154(3): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Mannion, M. L. Ormont, M. G. Magno, J. E. O'Brien, Y. Shi, and A. Zalewski Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts Ann. Thorac. Surg., December 1, 1998; 66(6): 1948 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gershlick Endovascular manipulation to restrict restenosis Vascular Medicine, August 1, 1998; 3(3): 177 - 188. [Abstract] [PDF]
|
|
|
|
 |
|
 J. D. Mannion, M. L. Ormont, Y. Shi, J. E. O'Brien Jr.,, W. Chung, F. Roque, and A. Zalewski Saphenous vein graft protection: Effects of c-myc antisense J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 152 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waltenberger Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases Circulation, December 2, 1997; 96(11): 4083 - 4094. [Abstract] [Full Text]
|
|
|
|
 |
|
 S NIKOL Possible uses of gene therapy in reducing coronary restenosis Heart, November 1, 1997; 78(5): 426 - 428. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Bennett, V. Lindner, D. DeBlois, M. A. Reidy, and S. M. Schwartz Effect of Phosphorothioated Oligonucleotides on Neointima Formation in the Rat Carotid Artery : Dissecting the Mechanism of Action Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2326 - 2332. [Abstract] [Full Text]
|
|
|
|
|
|
M. Husain, K. Bein, L. Jiang, S. L. Alper, M. Simons, and R. D. Rosenberg c-Myb–Dependent Cell Cycle Progression and Ca2+ Storage in Cultured Vascular Smooth Muscle Cells Circ. Res., May 19, 1997; 80(5): 617 - 626. [Abstract] [Full Text]
|
|
|
|
|
|
J. Gunn, C. M. Holt, S. E. Francis, L. Shepherd, M. Grohmann, C. M. H. Newman, D. C. Crossman, and D. C. Cumberland The Effect of Oligonucleotides to c-myb on Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Porcine Coronary Angioplasty Circ. Res., April 19, 1997; 80(4): 520 - 531. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A. M. Lincoff, R. Levy, and E. J. Topol Local Intraluminal Infusion of Biodegradable Polymeric Nanoparticles: A Novel Approach for Prolonged Drug Delivery After Balloon Angioplasty Circulation, September 15, 1996; 94(6): 1441 - 1448. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Pickering, J. M. Isner, C. M. Ford, L. Weir, A. Lazarovits, E. F. Rocnik, and L. H. Chow Processing of Chimeric Antisense Oligonucleotides by Human Vascular Smooth Muscle Cells and Human Atherosclerotic Plaque : Implications for Antisense Therapy of Restenosis After Angioplasty Circulation, February 15, 1996; 93(4): 772 - 780. [Abstract] [Full Text]
|
|